Exclusion Criteria:~* Have dementia or significant other neurological disease that can affect cognition.~* Have
current serious or unstable illnesses that in the investigator's opinion, could interfere with the analyses of
the study.~* Have a history of cancer that, in the investigator's opinion, has a high risk of recurrence.~*
Have a history of clinically significant multiple or severe drug allergies, or hypersensitivity reactions.~*
Have a clinically important laboratory test result or other abnormality as determined by investigator, prior to
randomization, that could be detrimental to the participant or could compromise the study.~* Have any
contraindications for magnetic resonance imaging (MRI).~* Have a centrally read MRI that does not meets study
entry criteria.~Prior or Current Therapies~* Have ever had prior treatment with a passive anti-amyloid
immunotherapy.~* Have received active immunization against AÎ² in any other study.
